1)日本泌尿器科学会,日本病理学会,日本医学放射線学会(編):前立腺癌取扱い規約,第4版.金原出版,東京,2010
2)Heidenreich PJBA(chair), Bellmunt J, Bolla SJM, et al:Guidelines on Prostate Cancer. European Association of Urology 2013, 2013
3)Roach M 3rd, Hanks G, Thames H, et al:Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer:recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 65:965-674, 2006
4)Pound CR, Partin AW, Eisenberger MA, et al:Natural history of progression after PSA elevation following radical prostatectomy. JAMA 281:1591-1597, 1999
5)Yokomizo A, Murai M, Baba S, et al:Percentage of positive biopsy cores, preoperative prostate-specific antigen(PSA)level, pT and Gleason score as predictors of PSA recurrence after radical prostatectomy:a multi-institutional outcome study in Japan. BJU Int 98:549-553, 2006
6)Consensus statement:Guidelines for PSA following radiation therapy. American Society for Therapeutic Radiology and Oncology Consensus Panel. Int J Radiat Oncol Biol Phys 37:1035-1041, 1997
7)Naito S:Evaluation and management of prostate-specific antigen recurrence after radical prostatectomy for localized prostate cancer. Jpn J Clin Oncol 35:365-374, 2005
8)Stephenson AJ, Kallan MW, Eastham JA, et al:Defining biochemical recurrence of prostate cancer after radical prostatectomy:a proposal for a standardized definition. J Clin Oncol 24:3973-3978, 2006
9)Freedland SJ, Humphreys EB, Mangold LA, et al:Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy. JAMA 294:433-439, 2005
10)Heidenreich PJBA(chair), Bellmunt J, Bolla M, et al:Guidelines on Prostate Cancer. European Association of Urology 2013, 2013
11)Cotter SE, Chen MH, Maul JW, et al:Salvage radiation in men after prostate-specific antigen failure and the risk of death. Cancer 117:3925-3932, 2011
12)Stephenson AJ, Scardino PT, Kattan MW, et al:Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. J Clin Oncol 25:2035-2041, 2007
13)Moul JW, Wu H, Sun L, et al:Early versus delayed hormonal therapy for prostate specific antigen only recurrence of prostate cancer after radical prostatectomy. J Urol 171:1141-1147, 2004
14)Choueiri TK, Chen MH, D'Amico AV, et al:Impact of postoperative prostate-specific antigen disease recurrence and the use of salvage therapy on the risk of death. Cancer 116:1887-1892, 2010
15)Patel C, Elshaikh MA, Angermeier K, et al:PSA bounce predicts early success in patients with permanent iodine-125 prostate implant. Urology 63:110-113, 2004
16)Agarwal PK, Sadetsky N, Konety BR, et al:Treatment failure after primary and salvage therapy for prostate cancer:likelihood, patterns of care, and outcomes. Cancer 112:307-314, 2008
17)Kojima S, Suzuki H, Akakura K, et al:Alternative antiandrogens to treat prostate cancer relapse after initial hormone therapy. J Urol 171:679-683, 2004